Kohjin Suzuki, Naoki Watanabe, Satoru Torii, Satoko Arakawa, Kiyosumi Ochi, Shun Tsuchiya, Kazuhiro Yamada, Yoko Kawamura, Sadao Ota, Norio Komatsu, et al. BCR::ABL1-induced mitochondrial morphological alterations as a potential clinical biomarker in chronic myeloid leukemia. Cancer science. 2024
Chiho Furuya, Yoshinori Hashimoto, Soji Morishita, Yasutaka Fukuda, Tadaaki Inano, Tomonori Ochiai, Shuichi Shirane, Yoko Edahiro, Marito Araki, Miki Ando, et al. A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera. Hematology (Amsterdam, Netherlands). 2024. 29. 1. 2427905-2427905
Yoko Edahiro, Tomonori Ochiai, Yoshinori Hashimoto, Michiko Ichii, Takeshi Okatani, Hiromi Omura, Kei Nakajima, Makoto Sasaki, Jun Ando, Tomoiku Takaku, et al. Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan. Hematology (Amsterdam, Netherlands). 2024. 29. 1. 2340149-2340149
Keita Kirito, Yuka Sugimoto, Akihiko Gotoh, Katsuto Takenaka, Michiko Ichii, Tadaaki Inano, Shuichi Shirane, Masafumi Ito, Oleh Zagrijtschuk, Albert Qin, et al. Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera. International journal of hematology. 2024
Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, et al. Correction to: Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology. 2024. 103. 10. 4349-4350
Yoko Edahiro, Shuichi Shirane, Jun Takeda, Hajime Yasuda, Tadaaki Inano, Miyuki Tsutsui, Yasuharu Hamano, Makoto Sasaki, Jun Ando, Atsuo Itakura, et al. Assessment and management of pregnancy in patients with myeloproliferative neoplasms: insights from a single-institution study of 29 neonates. International Journal of Hematology. 2024
杉本 由香, 小松 則夫. 真性多血症におけるロペグインターフェロンアルファ-2bの臨床的有用性 : 科学的エビデンスと臨床経験に基づいた知見-Clinical benefit of ropeginterferon alfa-2b for the patients with polycythemia vera : Based on scientific evidence and clinical experience. 血液内科 = Hematology / 血液内科編集委員会 編. 2023. 87. 5. 588-598
橋本 由徳, 枝廣 陽子, 伊藤 量基, 後藤 明彦, 中前 美佳, 木村 文彦, 小池 道明, 桐戸 敬太, 和田 秀穂, 臼杵 憲祐, et al. A nationwide survey on Japanese patients with essential thrombocythemia: JSH-MPN-R18 study(和訳中). 日本血液学会学術集会. 2021. 83回. OS3-3
安井 寛, 小林 真之, 佐藤 広太, 近藤 幹也, 石田 禎夫, 海渡 裕太, 田村 秀人, 半田 寛, 築根 豊, 佐々木 純, et al. セル・フリーDNAによる多発性骨髄腫の早期再発診断(Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse). International Journal of Myeloma. 2021. 11. 2. 91-91